Expression of Long-chain Fatty Acyl-CoA Synthetase 4 in Breast and Prostate Cancers Is Associated with Sex Steroid Hormone Receptor Negativity.
about
Long chain fatty Acyl-CoA synthetase 4 is a biomarker for and mediator of hormone resistance in human breast cancerLipid metabolism in prostate cancerBreast cancer molecular subtypes: from TNBC to QNBCTriple-negative breast cancer: is there a treatment on the horizon?Obesity and cancer progression: is there a role of fatty acid metabolism?Tyrosine phosphatase SHP2 regulates the expression of acyl-CoA synthetase ACSL4Very long-chain acyl-CoA synthetase 3: overexpression and growth dependence in lung cancerCancer cell-specific oligopeptides selected by an integrated microfluidic system from a phage display library for ovarian cancer diagnosis.Genome-wide Pathway Analysis Using Gene Expression Data of Colonic Mucosa in Patients with Inflammatory Bowel Disease.Lipid metabolism enzyme ACSVL3 supports glioblastoma stem cell maintenance and tumorigenicityFunctional interaction between acyl-CoA synthetase 4, lipooxygenases and cyclooxygenase-2 in the aggressive phenotype of breast cancer cells.The functional interaction between Acyl-CoA synthetase 4, 5-lipooxygenase and cyclooxygenase-2 controls tumor growth: a novel therapeutic target.Long-chain acyl-CoA synthetase in fatty acid metabolism involved in liver and other diseases: an updateColoLipidGene: signature of lipid metabolism-related genes to predict prognosis in stage-II colon cancer patients.Systematic Analysis of Gene Expression Alterations and Clinical Outcomes for Long-Chain Acyl-Coenzyme A Synthetase Family in Cancer.Acyl-CoA synthetase-4, a new regulator of mTOR and a potential therapeutic target for enhanced estrogen receptor function in receptor-positive and -negative breast cancerA link between lipid metabolism and epithelial-mesenchymal transition provides a target for colon cancer therapy.Analysis of large versus small dogs reveals three genes on the canine X chromosome associated with body weight, muscling and back fat thickness.Acyl-CoA metabolism and partitioning.17β-estradiol-induced ACSL4 protein expression promotes an invasive phenotype in estrogen receptor positive mammary carcinoma cells.ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition.Tumor-suppressive functions of long-chain acyl-CoA synthetase 4 in gastric cancer.ACSL4 promotes prostate cancer growth, invasion and hormonal resistance.Fatty acid metabolism in breast cancer subtypes.New molecular markers for prostate tumor imaging: a study on 2-methylene substituted fatty acids as new AMACR inhibitors.Cryptotanshinone inhibition of mammalian target of rapamycin pathway is dependent on oestrogen receptor alpha in breast cancer.Overexpression of Acyl-CoA Ligase 4 (ACSL4) in Patients with Hepatocellular Carcinoma and its Prognosis.Targeting Oct1 genomic function inhibits androgen receptor signaling and castration-resistant prostate cancer growth.Integrative transcriptome analysis of liver cancer profiles identifies upstream regulators and clinical significance of ACSM3 gene expression.Role of LOXs and COX-2 on FAK activation and cell migration induced by linoleic acid in MDA-MB-231 breast cancer cells.Signature molecules expressed differentially in a liver disease stage-specific manner by HIV-1 and HCV co-infection
P2860
Q21132473-9F4721EF-7EB4-440C-965D-14E30ED11E31Q27025766-6979081B-C13A-4628-849D-C6F7034FA55FQ28076805-63F229F6-4877-4C2B-9D22-F4BB0502C8FEQ28077243-F1411E14-8E19-4075-B698-DDABCA39F118Q28081152-9D7E0478-93F5-4120-8319-237A336597BDQ28247569-DB455749-6484-4385-BD9E-DEC9FC3CE5C1Q28534769-79F1B731-3E46-4CC8-91AF-3C1468660B17Q30418500-FFB6917F-6F65-4BB3-BBF8-A027F0FF4C35Q30938527-EE3FCD1B-0A71-41C2-B6AB-1C9B5037B534Q33747559-5C1F3AB1-D4EA-443D-B110-CAEB6C2781AEQ33750005-ABD399F1-1307-4E71-82F2-A4E78C01D5E9Q34342416-C95AEFBC-3C1C-4EF1-895B-D94E46404F93Q35221773-54E3177B-81CC-40AC-9CE9-A107AFF772E0Q35740226-08008E3A-8AE3-4B74-9E75-74A11AA62486Q36015852-9511F2E5-C44C-4D1C-BA99-C2B102ADE1DEQ36618951-18961A6B-641D-4A30-B01D-C41784403812Q36629402-83C87A6B-0002-44F2-8B49-F122AECEBA46Q37709745-5FF26611-5F70-4643-A8B6-41274C76FCAFQ38211152-F65F87D3-0BCB-45AD-8136-19BD124BDC96Q38711020-91C90F40-0929-446D-A7D2-5944492DE591Q38731136-B12C984B-23B1-4848-ACE9-ACA8E7C909D9Q38788430-0B8A68A2-54B5-468C-9B17-8231CE37FCC5Q38814389-89C7B149-EC72-457A-ADBD-4275FFE2AEC1Q38835370-7ABD0AD4-BFBB-4120-BC5C-752E6EE46900Q39496005-EB55F4FB-6550-489C-91FF-6A95C3977FEDQ41520280-5F7C0E26-6836-4500-B0A3-A4AAC51A0B09Q41700805-F3A1C2FE-227F-47CA-807D-E763A2F878D3Q42494288-21E33CC9-1B8A-4F7D-8F80-56DF4952B813Q53638858-DC20690A-FF7C-4ADB-9A88-0832DDC424C4Q54469665-94F4691F-4636-411E-9501-9EDFFA20B6DCQ58715600-96F00A34-311B-4F5A-81F3-23A893C47186
P2860
Expression of Long-chain Fatty Acyl-CoA Synthetase 4 in Breast and Prostate Cancers Is Associated with Sex Steroid Hormone Receptor Negativity.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Expression of Long-chain Fatty ...... d Hormone Receptor Negativity.
@ast
Expression of Long-chain Fatty ...... d Hormone Receptor Negativity.
@en
type
label
Expression of Long-chain Fatty ...... d Hormone Receptor Negativity.
@ast
Expression of Long-chain Fatty ...... d Hormone Receptor Negativity.
@en
prefLabel
Expression of Long-chain Fatty ...... d Hormone Receptor Negativity.
@ast
Expression of Long-chain Fatty ...... d Hormone Receptor Negativity.
@en
P2093
P2860
P356
P1476
Expression of Long-chain Fatty ...... d Hormone Receptor Negativity.
@en
P2093
Chad J Creighton
Diana M Stafforini
Marie E Monaco
Matthew K Topham
Xuanyi Zou
P2860
P356
10.1593/TLO.09202
P577
2010-04-01T00:00:00Z